Analysis of malaria recurrence and recrudescence in Gabon

September 27, 2026

By Fundación iO Team

Secondary study of data from the CANTAM study in Gabon, which evaluated the safety and efficacy of pyronaridine-artesunate in a real-world setting. 2,082 patients (adults and children weighing ≥ 5 kg) with uncomplicated malaria were included between June 2017 and March 2019. Of 1,687 patients in the per-protocol analysis, 129 (7.7%) experienced recurrence and 22 (1.3%) recrudescence. Repeated malaria episodes accounted for 17.4% of cases. Advanced age was associated with a lower risk of recurrence and recrudescence. Prior malaria increased the risk of recurrence and recrudescence, especially in young children. Targeted follow-up is needed for patients at higher risk of treatment failure.

COMPARTIR

Facebook
Twitter
LinkedIn